A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity
Conditions
Upper Limb Spasticity
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking Union Medical College Hospital, Beijing, China
Contact: Study coordinator (Xinhua Wan)West China Hospital，Sichuan University, Chengdu, China
Contact: Study coordinator (Huifang Shang)Guangdong Provincial People's Hospital, Guangdong, China
Contact: Study coordinator (Jiehao Zhao)Sun Yat-sen Memorial Hospital, Guangzhou, China
Contact: Study coordinator (Shaoling Wu)The Second People's Hospital of Hefei, Hefei, China
Contact: Study coordinator (Juncang Wu)Huai'an First Hospital Affiliated to Nanjing Medical University, Huai'an, China
Contact: Study coordinator (Yujun Qi)The First Affiliated Hospital of Henan University, Kaifeng, China
Contact: Study coordinator (Qingyan Qin)The Second Affiliated Hospital of Kunming Medical University, Kunming, China
Contact: Study coordinator (Liqing Yao)Shanghai Fudan University HuaShan Hospital, Shanghai, China
Contact: Study coordinator (Fang Li)Yangzhi Affiliated Rehabilitation Hospital of Tongji University, Shanghai, China
Contact: Study coordinator (Lingjing Jin)Shenzhen Second People's Hospital, Shenzhen, China
Contact: Study coordinator (Jianjun Long)The First Affiliated Hospital of Soochow University, Suzhou, China
Contact: Study coordinator (Qi Fang)Shanxi Bethune Hospital, Taiyuan, China
Contact: Study coordinator (pingzhi Wang)Tianjin Medical University General Hospital, Tianjin, China
Contact: Study coordinator (Xiaodong Zhu)Xuzhou Medical University Affiliated Hospital, Xuzhou, China
Contact: Study coordinator (Jie Xiang)Zibo Municipal Hospital, Zibo, China
Contact: Study coordinator (Runming Sun)